Influenza vaccination is associated with a reduced risk of invasive aspergillosis in high-risk individuals in Taiwan: a population-based cohort study

References

• Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020 Sep 12;71(6):1367–1376.
   PubMed Web of Science ®Google Scholar
• Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6(10):782–792.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Goncer I, Thomas S, Foden P, et al. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation. Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1251–1257.
   PubMed Web of Science ®Google Scholar
• Kuo CW, Wang SY, Tsai HP, et al. Invasive pulmonary aspergillosis is associated with cytomegalovirus viremia in critically ill patients – a retrospective cohort study. J Microbiol Immunol Infect. 2022 Apr;55(2):291–299.
   PubMedGoogle Scholar
• Rijnders BJA, Schauwvlieghe A, Wauters J. Influenza-associated pulmonary aspergillosis: a local or global lethal combination? Clin Infect Dis. 2020 Oct 23;71(7):1764–1767.
   PubMed Web of Science ®Google Scholar
• Schwartz IS, Friedman DZP, Zapernick L, et al. High rates of influenza-associated invasive pulmonary aspergillosis may not be universal: a retrospective cohort study from Alberta, Canada. Clin Infect Dis. 2020 Oct 23;71(7):1760–1763.
   PubMed Web of Science ®Google Scholar
• Verweij PE, Rijnders BJA, Bruggemann RJM, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020 Aug;46(8):1524–1535.
   PubMed Web of Science ®Google Scholar
• Ku YH, Chan KS, Yang CC, et al. Higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections. J Formos Med Assoc. 2017 Sep;116(9):660–670.
   PubMed Web of Science ®Google Scholar
• Grohskopf LA, Alyanak E, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 influenza season. MMWR Recomm Rep. 2021 Aug 27;70(5):1–28.
   PubMed Web of Science ®Google Scholar
• Yedlapati SH, Khan SU, Talluri S, et al. Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: a systematic review and meta-analysis. J Am Heart Assoc. 2021 Mar 16;10(6):e019636.
   PubMed Web of Science ®Google Scholar
• Modin D, Claggett B, Kober L, et al. Influenza vaccination is associated with reduced cardiovascular mortality in adults with diabetes: a nationwide cohort study. Diabetes Care. 2020 Sep;43(9):2226–2233.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Cao X, Cao Z, et al. Effects of influenza vaccination on the risk of cardiovascular and respiratory diseases and all-cause mortality. Ageing Res Rev. 2020 Sep;62:101124.
   PubMed Web of Science ®Google Scholar
• Taiwan Centers for Disease Control. Government-funded influenza vaccination program Taiwan. Taiwan Centers for Disease Control; 2021 [cited 2022 Feb 27]. Available from: https://www.cdc.gov.tw/Category/MPage/JNTC9qza3F_rgt9sRHqV2Q
   Google Scholar
• Hsieh CY, Su CC, Shao SC, et al. Taiwan’s national health insurance research database: past and future. Clin Epidemiol. 2019;11:349–358.
   PubMed Web of Science ®Google Scholar
• Taiwan Centers for Disease Control. Statistics of communicable diseases and surveillance report; [cited 2022 February 27]. Available from: https://www.cdc.gov.tw/En/InfectionReport/List/A1HdZwK8fUzN1IiBKDPkVQ
   Google Scholar
• Segaloff H, Melidou A, Adlhoch C, et al. Co-circulation of influenza A(H1N1)pdm09 and influenza A(H3N2) viruses, World Health Organization (WHO) European region, October 2018 to February 2019. Euro Surveill. 2019 Feb;24(9):1900125.
   PubMedGoogle Scholar
• Montrucchio G, Lupia T, Lombardo D, et al. Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements. Ann Intensive Care. 2021 Sep 15;11(1):136.
   PubMed Web of Science ®Google Scholar
• Blot SI, Taccone FS, Van den Abeele AM, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012 Jul 1;186(1):56–64.
   PubMed Web of Science ®Google Scholar
• Chang DC, Burwell LA, Lyon GM, et al. Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis. Infect Control Hosp Epidemiol. 2008 Jan;29(1):25–30.
   PubMed Web of Science ®Google Scholar
• Chapman WW, Dowling JN, Wagner MM. Generating a reliable reference standard set for syndromic case classification. J Am Med Inform Assoc. 2005 Nov-Dec;12(6):618–629.
   PubMed Web of Science ®Google Scholar
• Patel MM, York IA, Monto AS, et al. Immune-mediated attenuation of influenza illness after infection: opportunities and challenges. Lancet Microbe. 2021;2(12):e715–e725.
   PubMedGoogle Scholar
• Thompson MG, Pierse N, Sue Huang Q, et al. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015. Vaccine. 2018 Sep 18;36(39):5916–5925.
   PubMed Web of Science ®Google Scholar
• Modin D, Jorgensen ME, Gislason G, et al. Influenza vaccine in heart failure. Circulation. 2019 Jan 29;139(5):575–586.
   PubMedGoogle Scholar
• Lat A, Bhadelia N, Miko B, et al. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis. 2010 Jun;16(6):971–973.
   PubMed Web of Science ®Google Scholar
• Wauters J, Baar I, Meersseman P, et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med. 2012 Nov;38(11):1761–1768.
   PubMed Web of Science ®Google Scholar
• Chong WH, Saha BK, Tan CK. Clinical characteristics and outcomes of influenza-associated pulmonary aspergillosis among critically ill patients: a systematic review and meta-analysis. J Hosp Infect. 2022 Feb;120:98–109.
   PubMed Web of Science ®Google Scholar
• Garcia-Vidal C, Royo-Cebrecos C, Peghin M, et al. Environmental variables associated with an increased risk of invasive aspergillosis. Clin Microbiol Infect. 2014 Nov;20(11):O939–O945.
   PubMed Web of Science ®Google Scholar
• Liu JW, Ku YH, Chao CM, et al. Epidemiological correlation of pulmonary aspergillus infections with ambient pollutions and influenza A (H1N1) in southern Taiwan. J Fungi (Basel). 2021 Mar 19;7(3):227.
   PubMedGoogle Scholar
• Pebody R, Djennad A, Ellis J, et al. End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18. Euro Surveill. 2019 Aug;24(31):1800488.
   PubMedGoogle Scholar
• Belongia EA, McLean HQ. Influenza vaccine effectiveness: defining the H3N2 problem. Clin Infect Dis. 2019 Oct 30;69(10):1817–1823.
   PubMed Web of Science ®Google Scholar
• Shang M, Chung JR, Jackson ML, et al. Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012–2016. Vaccine. 2018 Dec 18;36(52):8047–8053.
   PubMed Web of Science ®Google Scholar
• Gershon AS, Chung H, Porter J, et al. Influenza vaccine effectiveness in preventing hospitalizations in older patients with chronic obstructive pulmonary disease. J Infect Dis. 2020 Jan 1;221(1):42–52.
   PubMed Web of Science ®Google Scholar
• Martinez-Baz I, Casado I, Navascues A, et al. Chronic obstructive pulmonary disease and influenza vaccination effect in preventing outpatient and inpatient influenza cases. Sci Rep. 2022 Mar 22;12(1):4862.
   PubMed Web of Science ®Google Scholar
• Samarakoon P, Soubani A. Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chron Respir Dis. 2008;5(1):19–27.
   PubMedGoogle Scholar
• Herbrecht R, Bories P, Moulin JC, et al. Risk stratification for invasive aspergillosis in immunocompromised patients. Ann N Y Acad Sci. 2012 Dec;1272:23–30.
   PubMed Web of Science ®Google Scholar
• Delsuc C, Cottereau A, Frealle E, et al. Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study. Crit Care. 2015 Dec 3;19:421.
   PubMed Web of Science ®Google Scholar
• Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology. 2010 May;21(3):383–388.
   PubMed Web of Science ®Google Scholar